Page 250 - FBL AR 2019-20

Fermenta Biotech Limited
Annual Report 2019-20

Information as required to be provided under Part II, Section II (iv) of Schedule V of the Companies Act, 2013 regarding Executive
Directors
Ms. Anupama Datla Desai Mr. Satish Varma
I. General Information - -
1 Nature of industry Pharmaceutical Pharmaceutical
2 Date or expected date of commencement of N.A. N.A.
commercial production
3 In case of new companies, expected date of N.A. N.A.
commencement of activities as per project
approved by financial institutions appearing
in the prospectus
4 Financial performance based on given As provided in the Board’s Report
indicators
5 Foreign investments or collaborations, if any. As on the date of the Notice, the Company has a wholly-owned subsidiary in the United Kingdom,
Germany and the United States of America each.
II. Information about the appointee: - -
1 Background details Brief profile of directors is provided in the previous table.
2 Past remuneration As provided in the Board’s report
3 Recognition or awards During the leadership of the directors, the Company has received the following awards among others:
• ‘Excellence in Corporate Social Responsibility’, ‘Excellence in Export Promotion’ and ‘Pharma International
Excellence’ awards at India Pharma Awards 2018
• The preferred supplier award for the eighth year in a row in Abbott Strategic Business Partner Award 2019;
• Hindustan Times Thane Ratna Award 2019 and 2020
• National Best Employer Brands 2018 at 27th Edition of Times Ascent presents World HRD Congress
• certified as ‘Great Place to Work’ by a global authority (Great Place to Work)
• won three awards at the prestigious World HRD Congress hosted by The Global Employer Branding
Institute
• Business Leader of the Year (Best Business Brands) in 2020 at Asia HRD Congress
4 Job profile and his suitability As provided in the brief profile of the directors set out in the previous table and the explanatory statement
to the AGM Notice.
5 Remuneration proposed As provided in the explanatory statement to the Notice.
6 Comparative remuneration profile with Considering her vast experience, expertise and Considering his expertise and overall experience
respect to industry, size of the company, being responsible for key areas of the Company’s for last several years in the company’s operations
profile of the position and person (in case of business operations, it is difficult to compare such and expansions it is difficult to compare such
expatriates the relevant details would be with remuneration profile with others. remuneration profile with others.
respect to the country of his origin)
7 Pecuniary relationship directly or indirectly There is no pecuniary relationship directly There is no pecuniary relationship directly
with the company, or relationship with the or indirectly with the company except the or indirectly with the company except the
managerial personnel, if any. remuneration and details mentioned in the related remuneration and details mentioned in the
party transactions in the financial statements. Ms. related party transactions in the financial
Rajeshwari Datla (director) is mother and Mr. Krishna statements. Details of shares held by the director
Datla (Managing Director) is brother of Ms. Anupama are provided in Corporate Governance Report.
Datla Desai. Details of shares held by the director are
provided in Corporate Governance Report.
III. Other information - -
1 Reasons of loss or inadequate profits The Company has been recording increase in its revenue and profits in recent years. However, the manner
of calculation of eligible profits for managerial remuneration as specified in Section 198 of the Companies
Act, 2013 may result in payment of remuneration in excess of the limits specified in Section 197 of the Act.
2 Steps taken or proposed to be taken for The Company has inter alia adopted the following measures to further improve the profitability:
improvement • strengthening its purchase, production, and sales and marketing functions
• established subsidiaries in the Europe and the USA in order to boost its sales and business across the
globe
• Technology upgradation by way of investing in state-of-the-art machinery to meet stringent quality
requirements of customers
• Cost control in all areas and focus on significant improvements in operating costs.
3 Expected increase in productivity and profits Barring unforeseen circumstances, the revenue earnings vis-à-vis profitability of the Company is expected
in measurable terms to increase in the coming years.

248